| Working memory, NIH Toolbox list sorting | Working memory in this test did not differ from placebo.Working memory, list sorting: 17±1→17±1 in both groups, group×time interaction p=0.97. | 1/4 Very lowPrecision of the estimate: No exact CI. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: The specific Longvida formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: 39 people and a battery of outcomes. | 11 trialCurcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗ | 39 healthy adults aged 45–74 | - Curcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗
|
|---|
| Episodic memory | Episodic memory in this test showed no difference from placebo.Picture sequence memory: curcumin 475.1±22.2→516.8±25.6, placebo 487.4±23.6→501.7±25.3; interaction p=0.3. | 1/4 Very lowPrecision of the estimate: No exact CI. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: The specific Longvida formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: 39 people and a battery of outcomes. | 11 trialCurcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗ | 39 healthy adults aged 45–74 | - Curcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗
|
|---|
| Processing speed | Processing speed in two tests showed no difference from placebo.Pattern comparison: interaction p=0.5; Trail Making A: p=0.6. | 1/4 Very lowPrecision of the estimate: No exact CI. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: The specific Longvida formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: 39 people and a battery of outcomes. | 11 trialCurcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗ | 39 healthy adults aged 45–74 | - Curcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗
|
|---|
| Executive function | Measures of executive function and attention in these tests did not differ from placebo.Dimensional change card sorting: interaction p=0.4; Trail Making B: p=0.9; Flanker attention test: p=0.97. | 1/4 Very lowPrecision of the estimate: No exact CI. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: The specific Longvida formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: 39 people and a battery of outcomes. | 11 trialCurcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗ | 39 healthy adults aged 45–74 | - Curcumin supplementation and motor-cognitive function in healthy middle-aged and older adults ↗
|
|---|
| Sum of days with individual symptoms | TS-P1: the sum of days with individual symptoms was lower than with placebo.38.6 versus 56.8; MD −18.2 (95% CI −35.1…−1.2). | 1/4 Very lowPrecision of the estimate: Small groups and broad uncertainty. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: Self-reported symptoms and a specific formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: Two active arms with a shared control, several outcomes. | 11 trialEffects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗ | 99 healthy Japanese adults, 33 in each group | - Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗
|
|---|
| Sum of days with individual symptoms | CR-033P: the sum of days with individual symptoms was lower than with placebo.39.4 versus 56.8; MD −17.4 (95% CI −34.3…−0.6). | 1/4 Very lowPrecision of the estimate: Small groups and broad uncertainty. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: Self-reported symptoms and a specific formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: Two active arms with a shared control, several outcomes. | 11 trialEffects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗ | 99 healthy Japanese adults, 33 in each group | - Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗
|
|---|
| Sum of maximum durations of individual symptoms | TS-P1: the sum of maximum durations of individual symptoms was lower than with placebo.22.3±30.2 versus 45.2±34.7; MD −22.9 (95% CI −39.4…−6.4). | 1/4 Very lowPrecision of the estimate: Small groups and broad uncertainty. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: Self-reported symptoms and a specific formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: Two active arms with a shared control, several outcomes. | 11 trialEffects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗ | 99 healthy Japanese adults, 33 in each group | - Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗
|
|---|
| Sum of maximum durations of individual symptoms | CR-033P: the sum of maximum durations of individual symptoms was lower than with placebo.27.8±33.1 versus 45.2±34.7; MD −17.4 (95% CI −33.8…−1.0). | 1/4 Very lowPrecision of the estimate: Small groups and broad uncertainty. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: Self-reported symptoms and a specific formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: Two active arms with a shared control, several outcomes. | 11 trialEffects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗ | 99 healthy Japanese adults, 33 in each group | - Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗
|
|---|
| Sneezing symptom-days | TS-P1: participants recorded fewer days of sneezing than with placebo.7.9±14.9 versus 18.4±18.6, p=0.026. | 1/4 Very lowPrecision of the estimate: Small groups and broad uncertainty. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: Self-reported symptoms and a specific formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: Two active arms with a shared control, several outcomes. | 11 trialEffects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗ | 99 healthy Japanese adults, 33 in each group | - Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗
|
|---|
| Runny nose symptom-days | TS-P1: participants recorded fewer days of runny nose than with placebo.9.8±14.8 versus 24.4±30.4, p=0.029. | 1/4 Very lowPrecision of the estimate: Small groups and broad uncertainty. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: Self-reported symptoms and a specific formulation. Possible publication bias: No specific data for a separate downgrade. Study methods: Two active arms with a shared control, several outcomes. | 11 trialEffects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗ | 99 healthy Japanese adults, 33 in each group | - Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study ↗
|
|---|